FDA approves new Alimta indicationThe FDA's approval of Lilly’s Alimta in combination with Merck's Keytruda, and platinum chemotherapy, is a breakthrough for patients with lung cancer. Mayne Pharma launches TolsuraMayne's launch of Tolsura provides a new treatment to fight life-threatening fungal infections. FDA approves new Imbruvica indication The Food and Drug Administration’s approval of Imbruvica in combination with obinutuzumab helps reduce the need for chemotherapy. Upsher-Smith celebrates its centennial As it marks a century in business, Upsher-Smith said its plans include diversifying and expanding its portfolio. Dr. Reddy’s gets FDA nod for Tosymra The Food and Drug Administration’s approval of Dr. Reddy's Tosymra provides a nasal spray for the acute treatment of migraine. Genentech appoints new CEO Genentech has named Alexander Hardy its CEO effective March 1, succeeding Bill Anderson. Aurobindo to acquire Spectrum’s oncology injectables portfolio Aurobindo is entering the branded oncology injectable space via an acquisition from Spectrum Pharmaceuticals. FDA approves new Cabometyx indication FDA's approval of a new Cabometyx indication provides a treatment for patients with liver cancer. FDA approves expanded use of Adacel vaccine Adacel is now the first and only Tdap vaccine in the United States approved for a repeat dose in people between the ages of 10-to-64 years old, administered eight or more years after the first vaccination. Amgen's Nplate pediatric indication gets FDA approval Amgen has received the Food and Drug Administration's approval for Nplate for pediatric patients with immune thrombocytopenia. First Previous 41 42 43 44 45 Next Last